Aquestive Therapeutics Inc.
10/16/2024 | Press release | Distributed by Public on 10/16/2024 15:17
Amendments to Bylaws Form 8 K
|
Item 5.03
|
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
On October 16, 2024, the Board of Directors (the "Board") of Aquestive Therapeutics, Inc. (the "Company"), in connection with its periodic review of corporate governance matters, approved amendments, effective immediately, to the Company's Amended and Restated Bylaws, as amended (the "Bylaws"). The Bylaws supersede the previously existing Amended and Restated Bylaws of the Company (the "Prior Bylaws"). Specifically, Article I, Section 11 of the Prior Bylaws, which sets forth requirements for stockholder nominations of candidates for election to the Board, has been amended to shorten the look-back period for required information concerning agreements, arrangements and understandings relating to stockholder nominations from three years to two years. In addition, the Prior Bylaws were amended to make certain technical and modernizing changes, namely, to replace all references to "chairman" with "chair."
The foregoing description is qualified in its entirety by reference to the full text of the Bylaws which are attached hereto as Exhibit 3.1 and incorporated herein by reference.